Drugs / Testosterone undecannoate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01397500 Comparator | Nov 2011 → Feb 2015 | pituitary deficiency | Max-Planck-Institute of Psychiatry | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Testosterone undecannoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01397500 ↗ |
| Action | Restore | “testosterone replacement in gonadotropin deficient patients compared to placebo treated control patients” NCT01397500 ↗ |
| Route | Intramuscular | “Testosterone undecannoate administered twice (6 week Interval) im by investigator.” NCT01397500 ↗ |